Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

RNL BIO CO., LTD, a leading biopharmaceutical company specialized in adult stem cell therapeutics, announced on January 21, 2011 another successful patient report utilizing stem cell therapy on a leading US orthopedic spine surgeon who suffered from Autoimmune Arthritis.

26 Jan 2011

UWE researcher receives two CSPCT grants to improve clinical delivery of treatments

A researcher from the University of the West of England has been awarded two grants to fund work that will encourage people with serious joint conditions to move and excercise more.

24 Jan 2011

U.S. Physical Therapy launches Fit2WRK to provide solutions for prevention of injuries in workplace

U.S. Physical Therapy, a national operator of outpatient physical therapy clinics, announced that it has successfully launched a workers compensation and disability initiative called Fit2WRK. Fit2WRK provides an integrated solution for the management and prevention of injuries in the workplace.

20 Jan 2011

Geron commences enrollment in imetelstat Phase 2 clinical trial in essential thrombocythemia

Geron Corporation today announced enrollment of the first patient in a Phase 2 clinical trial to evaluate the activity of the company's telomerase inhibitor drug, imetelstat (GRN163L), in patients with essential thrombocythemia (ET).

19 Jan 2011

Study shows physical activity helps people with osteoarthritis to walk faster

When a traffic light at a busy intersection flashes the WALK sign, people with knee osteoarthritis worry they can't walk fast enough to make it across the street in time. New Northwestern Medicine research shows people with this common arthritis are more likely to walk fast enough if they lead physically active lives.

19 Jan 2011

Uric acid levels linked to severe osteoarthritis

The amount of uric acid in one's joints may increase the likelihood of severe osteoarthritis, the most common form of arthritis worldwide, according to researchers at Duke University Medical Center.

19 Jan 2011

Painkillers and heart attack risk

A new study has shown that taking certain commonly used painkillers for long periods or in high doses increases the risk of heart attacks or strokes. The study comes from researchers from Bern University and is published in the British Medical Journal.

16 Jan 2011

NSAIDs raise risk of heart disease: Study

A new study published online in the British Medical Journal explores the relative safety of non-steroidal anti-inflammatory medications (NSAIDs), commonly used to treat joint and muscle aches and pain and concludes that NSAIDs significantly increase the risk of cardiovascular events in patients who take them regularly.

12 Jan 2011

Patients who consume painkillers may face cardiovascular risk

The drugs include traditional non-steroidal anti-inflammatory drugs as well as new generation anti-inflammatory drugs, known as COX-2 inhibitors. The researchers say that doctors and patients need to be aware that prescription of any anti-inflammatory drug needs to take cardiovascular risk into account.

12 Jan 2011

Study supports use of telomerase inhibitors for treatment of childhood cancers

Geron Corporation today announced the publication of preclinical data demonstrating that the company's telomerase inhibitor drug, imetelstat (GRN163L), currently in Phase 2 clinical trials, selectively targets cancer stem cells in pediatric tumors of neural origin.

11 Jan 2011

TransPharma reports positive results from ViaDerm-Calcitonin Phase 1 trial for musculoskeletal disorders

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a Phase I clinical trial of its self-applied ViaDerm-Calcitonin product for the treatment of musculoskeletal disorders such as osteoarthritis and musculoskeletal pain.

11 Jan 2011

Skin cells for repairing cartilage injury

In this paper, Noriyuki Tsumaki and his team at the Osaka University Graduate School of Medicine, used fibroblasts isolated from adult mouse skin, and expressed proteins used to induce pluripotency along with a factor that promotes a chondrocyte fate.

11 Jan 2011

Gigantism gene inherited by hundreds: Study

A gene that predicted gigantism in humans was identified in the DNA of the 18th-century man known as the Irish Giant, who was more than 7 feet 7 inches tall. Copies of the same mutation have been found in patients today who suffer from excessive growth, and scientists have concluded they all inherited the gene from a common ancestor.

9 Jan 2011

InHealth awards grant to assess effects of hip replacement therapy on aging populations

The Institute for Health Technology Studies has awarded a grant of $240,000 to an international consortium of researchers, for a study that will assess the effects of hip replacement therapy on the employment and retirement decisions of older adults. Led by researchers at the Universit- Bocconi (Milan), the consortium also includes investigators at the University of York (York, UK), and the Johns Hopkins University School of Public Health (Baltimore).

6 Jan 2011

Pico-Tesla commences placebo-controlled Magneceutical Therapy study for Alzheimer's disease

Pico-Tesla, The Magneceutical Company, announced that it has commenced a randomized, double-blind, placebo-controlled pilot study of 30 patients who have Alzheimer's disease symptoms.

6 Jan 2011

Carbylan completes enrollment in COR1.0 feasibility trial of Hydros and Hydros TA in knee osteoarthritis

Carbylan BioSurgery, Inc. announced today the completion of patient enrollment in their double-blinded, multi-center COR1.0 feasibility trial to evaluate the safety and effectiveness of two products - Hydros and Hydros TA Joint Therapies - in patients with osteoarthritis of the knee. Hydros and Hydros TA are next generation viscosupplement and viscosupplement/steroid combination products.

5 Jan 2011

New research finds physicians are not following standard care guidelines for OA

New research found clinicians who care for patients with osteoarthritis are likely not following standard care guidelines that are based on current medical evidence.

5 Jan 2011

Pico-Tesla announces expansion of Magneceutical Phase III trail for Parkinson's disease

Pico-Tesla, The Magneceutical Company, announced that it has expanded its ongoing Phase III pivotal clinical trial by adding three Principal Investigators, including two university-affiliated clinicians: one in Denver; and one in Tampa.

5 Jan 2011

Clinicians rely upon analgesics and surgery; overlook exercise and weight loss for OA patients

New research found clinicians who care for patients with osteoarthritis (OA) are likely not following standard care guidelines that are based on current medical evidence. Researchers noted physicians were prescribing medications for pain and inflammation, or opting for surgical interventions rather than recommending weight loss plans or exercise programs to OA patients.

4 Jan 2011

U.S. Physical Therapy acquires majority interest in 14 clinic physical therapy group

U.S. Physical Therapy, Inc., a leading national operator of outpatient physical therapy clinics, has acquired a majority interest in a 14 clinic physical therapy group located in the Southeast.

3 Jan 2011

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

UWE researcher receives two CSPCT grants to improve clinical delivery of treatments

U.S. Physical Therapy launches Fit2WRK to provide solutions for prevention of injuries in workplace

Geron commences enrollment in imetelstat Phase 2 clinical trial in essential thrombocythemia

Study shows physical activity helps people with osteoarthritis to walk faster

Uric acid levels linked to severe osteoarthritis

Painkillers and heart attack risk

NSAIDs raise risk of heart disease: Study

Patients who consume painkillers may face cardiovascular risk

Study supports use of telomerase inhibitors for treatment of childhood cancers

TransPharma reports positive results from ViaDerm-Calcitonin Phase 1 trial for musculoskeletal disorders

Skin cells for repairing cartilage injury

Gigantism gene inherited by hundreds: Study

InHealth awards grant to assess effects of hip replacement therapy on aging populations

Pico-Tesla commences placebo-controlled Magneceutical Therapy study for Alzheimer's disease

Carbylan completes enrollment in COR1.0 feasibility trial of Hydros and Hydros TA in knee osteoarthritis

New research finds physicians are not following standard care guidelines for OA

Pico-Tesla announces expansion of Magneceutical Phase III trail for Parkinson's disease

Clinicians rely upon analgesics and surgery; overlook exercise and weight loss for OA patients

U.S. Physical Therapy acquires majority interest in 14 clinic physical therapy group

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in